Recruiting NA Primipara Pregnant

New treatment option for Primipara Pregnant

Official title The Effect of Birth Positions on Labor

ClinicalTrials.gov ID: NCT07243522

What this study is testing

What it's testing
This study is a randomized controlled trial aimed at evaluating the effects of positions used during labor on pelvic floor muscle strength and the severity and nature of perineal pain in primiparous pregnant women. The World Health Organization (WHO) recommends supporting women's freedom of movement during the second stage of labor and encouraging upright birthing positions.
  • Which group you join is decided by chance.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 to 35, women only. Healthy volunteers may be eligible.

You may be able to join if

  • Being between 18 and 35 years of age
  • Being primiparous
  • Being at term (37-42 weeks)
  • Being in the latent phase of the first stage of labor
  • Being in the vertex position, having a single, live fetus

You likely can't join if

  • Non-cephalic presentation
  • Chronic diseases (heart disease, epilepsy, hypertension, hypothyroidism, diabetes, and kidney disease, etc.)
  • Risk of obstetric complications (gestational hypertension, cephalopelvic disproportion, antepartum hemorrhage, intrauterine growth restriction...
  • History of pelvic surgery
  • History of prolapse surgery
  • History of collagen disorder
See the full eligibility criteria
Who can join
  • Being between 18 and 35 years of age
  • Being primiparous
  • Being at term (37-42 weeks)
  • Being in the latent phase of the first stage of labor
  • Being in the vertex position, having a single, live fetus
  • Having an estimated fetal weight between 2500 and 4000 grams
  • Having a maternal Body Mass Index \<30
  • Pregnant women who are expected to give birth vaginally
  • Ability to understand and speak Turkish
  • Volunteer to participate in the study
What rules you out
  • Non-cephalic presentation
  • Chronic diseases (heart disease, epilepsy, hypertension, hypothyroidism, diabetes, and kidney disease, etc.)
  • Risk of obstetric complications (gestational hypertension, cephalopelvic disproportion, antepartum hemorrhage, intrauterine growth restriction, premature rupture of membranes, etc.)
  • History of pelvic surgery
  • History of prolapse surgery
  • History of collagen disorder
  • Severe anemia
  • Presence of genital tract infection
  • Abnormalities of the vulva (presence of vulvar edema, scarring, etc.)
  • Application of fundal pressure
  • treatment delivery (use of forceps/vacuum during the second stage, etc.)
  • Cesarean section
  • Fetal (risk/presence of congenital malformations, estimated fetal weight \ 4000 g)

The study team makes the final eligibility decision.

Where it's taking place

  • Izmir, Turkey (Türkiye)

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling female, 18 years to 35 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Izmir, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.